NCT04394052 Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II
| NCT ID | NCT04394052 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Central Hospital, Nancy, France |
| Condition | Soft Tissue Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 740 participants |
| Start Date | 2020-06-01 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 740 participants in total. It began in 2020-06-01 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims at evaluating the value of various artificial intelligence based techniques to improve the characterization and image post-processing for patients with musculoskeletal tumors.
Eligibility Criteria
Inclusion Criteria: * Patients suspected to have a bone or soft-tissue tumor referred for imaging for initial tumors characterization and staging. Exclusion Criteria: * Pregnancy * Breast feeding patients * Renal insufficiency * Contra indications to MRI or CT * Prior surgery or treatment to the evaluated lesion.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04394052 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Soft Tissue Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04394052 currently recruiting?
Yes, NCT04394052 is actively recruiting participants. Contact the research team at p.teixeira@chru-nancy.fr for enrollment information.
Where is the NCT04394052 trial being conducted?
This trial is being conducted at Nancy, France.
Who is sponsoring the NCT04394052 clinical trial?
NCT04394052 is sponsored by Central Hospital, Nancy, France. The trial plans to enroll 740 participants.